Pilatus Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, today announced the first patient ...

Late last year, I nearly passed out in my girlfriend’s bed. I had forgotten to breathe for what felt like a couple of minutes until, finally, I gasped, gulping hot air. My balls ached. My temples ...

In ‘Evaluating Transthyretin Stabilizers and Silencers in ATTR-CM,’ our panel delves into the segment by asking Dr. Alexander to explain the differences between transthyretin ...

Proven human resources and organizational strategist brings more than two decades of leadership across the pharmaceutical industryAppointment ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...

First-in-human study underway evaluating anti-CD36 monoclonal antibody designed to restore metabolic fitness in exhausted T cells, reduce immunosuppressive cells, and enhance antitumor immunity ...

WSJ writer Eli Thompson has seen first hand how sports betting ruins young men.He recalled seeing “One of my football ...

Rural school districts say the Trump administration’s visa changes are jeopardizing a key source of teachers. Many schools hired foreign teachers when they couldn't attract American instructors to ...